Live Breaking News & Updates on Infographic Labconnect
Stay updated with breaking news from Infographic labconnect. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
03.08.21 Appili s CRO Selection Reflects Realities Of Clinical Studies In A Pandemic
Orphan drugs are notorious for their high costs and risk factors, which are attributed to smaller patient pools and higher development and launch costs.
Attend this webinar to learn more about key trends that are causing the rise of orphan drug indications, fast-tracking early development phases that will lead to commercial success, and more!
By Ed Miseta, chief editor, Clinical Leader When Appili Therapeutics was ready to enter a Phase 3 trial for a COVID-19 treatment, the CRO selection process was tightly linked to the fact that the company would be conducting the study on infected patients during a global pandemic. ....